Why Did Carlos Slim Buy PBF Energy?
Carlos Slim made a splash in a surprising sector last…
Sell
44
CGTX Quote, Financials, Valuation and Earnings
Last price:
$0.75
Seasonality move
:
-20.79%
Day range:
$0.67 - $0.77
52-week range:
$0.34 - $2.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.07x
Volume:
2.1M
Avg. volume:
14.5M
1-year change:
-62.73%
Market cap:
$30M
Revenue:
--
EPS (TTM):
-$0.97
Earnings Data
Next earnings date for CGTX
Mar 26
2025
Most recent earnings per share
-$0.25
Missed by $0.04
(Nov 13/2024)
Consensus Estimate
-$0.21
(Nov 13/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CGTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | -- | -- | -- | -$0.12 | -- |
| 03/26/2025 | Q4 | -- | -- | -- | -$0.19 | -- |
| 11/13/2024 | Q3 | -- | -- | -$0.25 | -$0.21 | -$0.04 |
| 08/08/2024 | Q2 | -- | -- | -$0.18 | -$0.23 | $0.05 |
| 05/07/2024 | Q1 | -- | -- | -$0.27 | -$0.25 | -$0.03 |
| 03/26/2024 | Q4 | -- | -- | -$0.27 | -$0.33 | $0.06 |
| 11/02/2023 | Q3 | -- | -- | -$0.22 | -$0.29 | $0.07 |
| 08/08/2023 | Q2 | -- | -- | -$0.16 | -$0.21 | $0.05 |
| 05/04/2023 | Q1 | -- | -- | -$0.21 | -$0.18 | -$0.04 |
| 03/23/2023 | Q4 | -- | -- | -$0.20 | -$0.30 | $0.10 |
| 11/14/2022 | Q3 | -- | -- | -$0.29 | -- | -- |
| 08/09/2022 | Q2 | -- | -- | -$0.25 | -- | -- |
| 05/11/2022 | Q1 | -- | -- | -$0.17 | -- | -- |
| 03/30/2022 | Q4 | -- | -- | -$0.34 | -- | -- |
| 11/17/2021 | Q3 | -- | -- | -$0.24 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.14 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.04 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.14 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.13 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.17 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.12 | -- | -- |
Cognition Therapeutics Earnings Questions
-
How Much did Cognition Therapeutics Generate in Revenue Last Quarter?
Cognition Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Cognition Therapeutics Beat Earnings Last Quarter?
Cognition Therapeutics announced earnings per share of -$0.25 which represents a miss of analyst forecast a -$0.21 per share.
-
Is Cognition Therapeutics Profitable?
Cognition Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Cognition Therapeutics EPS Next Year?
Cognition Therapeutics's earnings are forecast to decrease from -$0.86 per share to -$0.85 per share next year representing a decrease of -11.63%.
-
When is Cognition Therapeutics's Earnings Date?
Cognition Therapeutics's next earnings date is March 26, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Booking Holdings Stock Undervalued?
There is a lot of humdrum in the market about…
Broadcom vs American Express: Which Is Best?
Chip giant Broadcom Inc. (NASDAQ:AVGO) and card company American Express…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 116x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Sell
47
DRUG alert for Jan 3
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Buy
88
BMA alert for Jan 3
Banco Macro SA [BMA] is up 0.88% over the past day.
Sell
50
AGFY alert for Jan 3
Agrify [AGFY] is down 5.86% over the past day.
